Press Releases

Proscia to Broaden Pathology AI Capabilities with Biomarker Detection for Skin Tissue

Proscia®, a pathology AI company, will add AI biomarker detection for skin tissue to its Concentriq® software platform, empowering pathologists to drive efficiency and precision. Powered by Primaa, Cleo Skin* will strengthen Concentriq's lead in offering the industry’s broadest portfolio of AI solutions on a single platform.

Baylor Genetics Presents New Data on Clinical and Diagnostic Utility of RNA Sequencing for Rare Disease at the American Society of Human Genetics 2025 Annual Meeting

Baylor Genetics Presents New Data on Clinical and Diagnostic Utility of RNA Sequencing for Rare Disease at the American Society of Human Genetics 2025 Annual Meeting

Scanogen Receives FDA Breakthrough Device Designation for Rapid Bloodstream Infection Assay

Scanogen Inc., a Maryland-based molecular diagnostics company, announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its rapid assay for bloodstream infection pathogen identification. The company’s SMART platform delivers species-level results in just two hours—compared to several days with current blood culture methods—enabling earlier, targeted antimicrobial therapy that can improve sepsis outcomes and reduce healthcare costs. Supported by multiple NIH research grants, Scanogen is now raising a Series A financing round to fund pivotal clinical studies and bring this transformative technology to market.

Gifthealth is First to Serve 6m Patients Via Direct-to-Patient Platform

Gifthealth, the patient access solution that unifies the prescription journey from provider to patient, today announced it has now served more than six million patients through its direct-to-patient (DTP) platform.

CluePoints’ AI Breakthroughs Earn Dual Recognition at SCDM and SCRIP Awards

CluePoints, provider of leading statistical and AI-driven software solutions, has achieved dual recognition, winning the Clinical Data Science Implementation Excellence Award at the 2025 SCDM Annual Conference and has been named a finalist in the ‘Best Contract Research Organization– Specialist Providers’ category at the 2025 SCRIP Awards.

Association for Molecular Pathology Develops Standardized Biomarker Report Template for Providers

AMP announced the publication of a new simplified, consensus-driven NGS molecular biomarker report designed to support oncologists and other healthcare providers. This report provides clear, practical recommendations to help laboratories present complex molecular profiling data in a format that is both clinically useful and consistent with current guidelines.

Phastar Scoops Multiple Finalist Positions in 2025 SCRIP Awards

Phastar, a global specialist biometrics & data science Contract Research Organization (CRO), has been named as finalists in two categories at the prestigious 2025 SCRIP Awards.

Baylor Genetics Earns 2025 Great Place To Work Certification™

Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, is proud to be Certified™ by Great Place To Work®! The prestigious award is based entirely on what current employees say about their experience working at Baylor Genetics. This recognition is based entirely on feedback from current employees about their workplace experience. In 2025, Baylor Genetics employees rated the company 17 points higher than the average U.S. workplace.

Ambience Healthcare Becomes First Ambient AI Platform to Launch Inpatient CDI at the Point of Care, Built on OpenAI

Clearwater Receives Strategic Growth Investment from Sunstone Partners

P&C Labs Achieves Immediate Efficiency Gains with Proscia’s Software

Pathologists readily embrace the shift to digital workflows.

Scanogen Awarded NIH 2.9M Grant to Advance Rapid Test for Life-Threatening Bloodstream Infections

Baltimore, MD – Sept 22, 2025 – Scanogen Inc. has received a $2.9 million grant from the NIH/NIAID to scale its rapid diagnostic platform for life-threatening yeast bloodstream infections. Powered by proprietary SMART technology, the system delivers results directly from blood samples in hours—far faster than traditional blood cultures. The funding will support FDA-compliant production, software upgrades, and preparation for clinical trials. CEO Dr. Al Celedon stated the grant is a major step toward faster diagnosis and improved patient survival.

ClearNote Health Receives In Vitro Diagnostic Approval in United Kingdom for Avantect® Multi-Cancer Detection Test and Avantect® Ovarian Cancer Test

ClearNote Health receives UKCA markings for both the Avantect Ovarian Test and the Avantect Multi-Cancer Detection Test.

Takara Bio Europe Launches Cellartis® MSC EV Wonder™, a Defined, Xeno-Free Medium for High-Yield EV Production

Takara Bio Europe announces the launch of Cellartis® MSC EV Wonder

Ambience Healthcare Launches Real-Time HCC Compliance Validator to Reduce Audit Risk and Strengthen Documentation Integrity

Proscia to Expand Pathology AI Capabilities with Virtual Staining

Delivering a menu of H&E, IHC, and special stains on the Concentriq platform

Carolina Molecular Inc. and Astoriom to Collaborate on Integrated Molecular Testing and Biospecimen Storage Services

Research Triangle Park-based companies provide comprehensive testing and sample storage to CROs, CDMOs, Pharma and Biotech Partners

Arkivum announces new partnership with unified trial management platform provider PHARMASEAL

Arkivum is delighted to announce a new partnership with PHARMASEAL, the provider of the Engility® Trial Management Platform, consisting of a Clinical Trial Management System (CTMS) and Electronic Trial Master File (eTMF).

Baylor Genetics’ Chief Medical Officer Dr. Christine Eng Named Woman Scientist of the Year in 2025 Stevie® Awards for Women in Business

Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, today announced that Chief Medical Officer and Chief Quality Officer Dr. Christine Eng has been named Woman Scientist of the Year in the 22nd annual Stevie Awards for Women in Business.

electronRx to Launch pDx App for Remote Chronic Respiratory Disease Management

● Technology detects digital biomarkers to help monitor lung function and optimise therapeutic outcomes for patients ● electronRx to showcase pDx at HLTH 2025 (19–22 Oct, Las Vegas)